These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12439626)

  • 1. Nefazodone decreases anxiety during marijuana withdrawal in humans.
    Haney M; Hart CL; Ward AS; Foltin RW
    Psychopharmacology (Berl); 2003 Jan; 165(2):157-65. PubMed ID: 12439626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marijuana withdrawal in humans: effects of oral THC or divalproex.
    Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW
    Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
    Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion SR worsens mood during marijuana withdrawal in humans.
    Haney M; Ward AS; Comer SD; Hart CL; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 2001 May; 155(2):171-9. PubMed ID: 11401006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
    Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
    J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse.
    Haney M; Hart CL; Vosburg SK; Comer SD; Reed SC; Foltin RW
    Psychopharmacology (Berl); 2008 Mar; 197(1):157-68. PubMed ID: 18161012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of smoked marijuana in healthy and HIV + marijuana smokers.
    Haney M
    J Clin Pharmacol; 2002 Nov; 42(S1):34S-40S. PubMed ID: 12412834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.
    Haney M; Cooper ZD; Bedi G; Vosburg SK; Comer SD; Foltin RW
    Neuropsychopharmacology; 2013 Jul; 38(8):1557-65. PubMed ID: 23443718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute doses of d-amphetamine and bupropion increase cigarette smoking.
    Cousins MS; Stamat HM; de Wit H
    Psychopharmacology (Berl); 2001 Sep; 157(3):243-53. PubMed ID: 11605079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers.
    Cooper ZD; Foltin RW; Hart CL; Vosburg SK; Comer SD; Haney M
    Addict Biol; 2013 Nov; 18(6):993-1002. PubMed ID: 22741619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of repeated doses of caffeine on performance and alertness: new data and secondary analyses.
    Hewlett P; Smith A
    Hum Psychopharmacol; 2007 Aug; 22(6):339-50. PubMed ID: 17514640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
    Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
    Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.
    Haney M; Hart CL; Vosburg SK; Comer SD; Reed SC; Cooper ZD; Foltin RW
    Psychopharmacology (Berl); 2010 Aug; 211(2):233-44. PubMed ID: 20521030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abstinence symptoms following smoked marijuana in humans.
    Haney M; Ward AS; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 1999 Feb; 141(4):395-404. PubMed ID: 10090647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study.
    Winstock AR; Lea T; Copeland J
    J Psychopharmacol; 2009 Jan; 23(1):84-93. PubMed ID: 18515451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
    Ciraulo DA; Knapp C; Rotrosen J; Sarid-Segal O; Ciraulo AM; LoCastro J; Greenblatt DJ; Leiderman D
    Addiction; 2005 Mar; 100 Suppl 1():23-31. PubMed ID: 15730347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychostimulant and other effects of caffeine in 9- to 11-year-old children.
    Heatherley SV; Hancock KM; Rogers PJ
    J Child Psychol Psychiatry; 2006 Feb; 47(2):135-42. PubMed ID: 16423144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory.
    van Laar MW; Volkerts ER; Verbaten MN; Trooster S; van Megen HJ; Kenemans JL
    Psychopharmacology (Berl); 2002 Aug; 162(4):351-63. PubMed ID: 12172688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
    Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
    Psychopharmacology (Berl); 2016 Jul; 233(13):2469-78. PubMed ID: 27085870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.